{
    "title": "Bristol-Myers wins approval for 1st hepatitis C type 3 drug",
    "url": "https://www.dailymail.co.uk/wires/ap/article-3173810/Bristol-Myers-wins-approval-1st-hepatitis-C-type-3-drug.html",
    "date": "2015-07-24",
    "keywords": [
        "drug",
        "treatment",
        "hepatitis",
        "percent",
        "liver",
        "sovaldi",
        "c",
        "daklinza",
        "harvoni",
        "market",
        "technivie",
        "pill",
        "price",
        "day",
        "gmt",
        "july",
        "co",
        "blockbuster",
        "leader",
        "gilead",
        "combination",
        "virus",
        "cirrhosis",
        "johnson",
        "december",
        "viekira",
        "pak",
        "cure",
        "list",
        "course",
        "cost",
        "ribavirin",
        "approval",
        "type",
        "press",
        "email",
        "trenton",
        "nj",
        "hardesttotreat",
        "food",
        "administration",
        "surge",
        "virusdaklinza",
        "form",
        "fda",
        "friday",
        "inc",
        "genotype",
        "mucholder",
        "generic",
        "ribavirindaklinza",
        "week",
        "august",
        "spate",
        "idea",
        "damage",
        "function",
        "failure",
        "transplant",
        "cancer",
        "jaundice",
        "fluid",
        "side",
        "year",
        "victrelis",
        "olysio",
        "incs",
        "time",
        "patient",
        "disease",
        "example",
        "blood",
        "testing",
        "total",
        "daclatascir",
        "condition",
        "escalation",
        "prescription",
        "medicinesthe",
        "trend",
        "alarm",
        "ability",
        "government",
        "health",
        "percentage",
        "number",
        "drugstheir",
        "payment",
        "assistance",
        "money",
        "care",
        "battle",
        "supremacy",
        "head",
        "start",
        "ingredient",
        "secondquarter",
        "tuesdayabbvie",
        "worldwide",
        "disadvantage"
    ],
    "category": [
        "wires",
        "ap"
    ]
}